|
Effects of Miconazole on Blood Flow Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Effects of Miconazole on Blood Flow conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Effects of Miconazole on Blood Flow Clinical research trials and Effects of Miconazole on Blood Flow medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Effects of Miconazole on Blood Flow. Effects of Miconazole on Blood Flow Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Effects of Miconazole on Blood Flow clinical trial. Participants frequently get the best healthcare available for their Effects of Miconazole on Blood Flow condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Effects of Miconazole on Blood Flow  Effects of Miconazole on Blood Flow
Effects of Miconazole on Blood Flow
For Condition: Healthy
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: This study will investigate the effect of the drug miconazole on blood vessel dilation. Miconazole stops production of EDHF, a substance that causes arteries to dilate. EDHF is produced by the cells that line blood vessels. Normal volunteers between the ages of 21 to 60 may participate in this study. Candidates will be screened for eligibility with a medical history, physical examination, electrocardiogram and routine laboratory tests. Those enrolled will be injected with miconazole to study its effects on blood vessels. Study participants will take three aspirin tablets. After administration of a local anesthetic, small tubes will be inserted through a needle into the artery and vein of the forearm. These will be used to measure blood pressure and to draw blood samples during the study. Forearm blood flow will be measured using pressure cuffs placed on the wrist and upper arm, and a strain gauge (a rubber band device) placed around the forearm. When the cuffs are inflated, blood will flow into the arm, stretching the strain gauge, and the flow measurement will be recorded. Small doses of four drugs-bradykinin, sodium nitroprusside, miconazole, and LNMMA-will be given through the arterial catheter. Bradykinin stimulates the release of EDHF and can lower blood pressure. Sodium nitroprusside causes blood vessels to dilate and is used to treat high blood pressure and heart failure. Miconazole is commonly prescribed to treat various infections, including vaginal yeast infections, jock itch and athlete's foot. In much higher doses, it is used to treat fungal infections that have spread to the lungs, brain, kidneys, or bladder. LNMMA inhibits production of nitric oxide, another substance produced by the lining cells of blood vessels. Blood flow will be measured throughout the study, which will last approximately 3 hours.
Details: The vascular endothelium synthesizes at least three potent vasodilator substances: nitric oxide (NO), prostacyclin and an endothelium-derived hyperpolarizing factor (EDHF). EDHF release is stimulated by receptor-dependent agonists such as acetylcholine and bradykinin (BK), and leads to hyperpolarization of the underlying smooth muscle cells presumably by opening Ca(2+)-activated K(+) channels. Indirect pharmacologic evidence suggests that EDHF is a cytochrome P450-derived arachidonic acid metabolite, presumably an epoxide. Numerous inhibitors of EDHF have been defined in animal tissues. Of these, miconazole has proven to be safe when administered to humans as a topical and parenteral antifungal agent. At levels that are attained with routine clinical use, it has a rapid onset of action with high specificity of inhibition of EDHF in animal models. This study is designed to investigate the safety and efficacy of intra-arterial miconazole in inhibiting BK-mediated forearm vasodilation in normal volunteers.
Eligibility:
Study Type: Interventional, Treatment, Safety
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Healthy male or female volunteers (age 21-60 years). No presence of intercurrent illness. No current smoking (within previous 5 years). No hypertension (greater than 140/90). No diabetes. No hypercholesterolemia (total cholesterol greater than 240 mg/dl). No pregnancy or menopause. No renal failure (creatinine greater than 1.4 mg/dl). No allergies to miconazole, parabens, castor oil or aspirin. No bleeding disorders. No consumption of any medications during the last one week, including vitamins and unconventional medications.
Total Enrollment: 15
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 000077; 00-H-0077
Study Start Date: February 11, 2000
Record last reviewed: October 16, 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004575
Other Healthy Studies:
1. Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers
2. Lipoprotein Metabolism in Normal Volunteers and Patients with Abnormal Levels of Lipoproteins
3. Test of QLS Device to Detect Early Cataracts
4. Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914
5. Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Effects of Miconazole on Blood Flow
|
|
|
|
|
|
|
|
